†rsrapport Nycomed - Takeda Pharmaceuticals International GmbH

ACCOUNTSCONSOLIDATED PROFIT AND LOSS STATEMENTNote 2000 1998/99(000)DKK(000)DKK7 months1 Net turnover 3,428,631 1,901,8402+3 Cost of sales - 1,650,122 - 994,384GROSS PROFIT 1,778,509 907,4562+3 Sales and marketing expenses - 1,148,326 - 606,5762+3 Research and development expenses - 58,465 - 39,9492+3 Administration expenses - 294,484 - 173,601Other operating income 15,919 6,259OPERATING RESULT 293,153 93,589Restructuring expenses - 119,519 0RESULT BEFORE FINANCIAL ITEMS AND TAX 173,634 93,589Financial income 36,716 62,557Financial expenses - 267,828 - 210,776RESULT BEFORE TAX - 57,478 -54,6304 Income tax expenses 14,268 - 2,439NET RESULT - 43,210 -57,069–45–